Current Controlled Trials - Search the ISRCTN Register of Clinical Trials.

Welcome

12 March 2010

	Trial registration
	Unique identification scheme
	International databases

Find trials

ISRCTN Register

Registration

New application

Updating record

Information

introduction

governing board

ISRCTN FAQs

data set

guidance notes

International Standard Randomised Controlled Trial Number Register

Showing records: 7761 to 7770 of 8362

SEARCH FOR	RESULTS ORDER	DIRECTION	MAX RESULTS

7761	A randomised trial of maintenance weekly paclitaxel versus observation following remission with first-line induction carboplatin and paclitaxel for patients with ovarian cancer
	ISRCTN:	ISRCTN48397858
	Sponsor:	The Institute of Cancer Research (UK)
	Date assigned:	15 October 2002

7762	A randomised trial of custom-made compensators versus standard wedge compensators for breast radiotherapy
	ISRCTN:	ISRCTN48733595
	Sponsor:	Cancer Research UK (CRUK) (UK)
	Date assigned:	15 October 2002

7763	A phase II/III randomised trial comparing Epirubicin, Cisplatin and Protracted Venous Infusion (PVI) 5-Fluorouracil (5-FU) (ECF), Epirubicin, Oxaliplatin and PVI 5-FU (EOF), Epirubicin, Cisplatin and Capecitabine (ECX) and Epirubicin, Oxaliplatin and Capecitabine (EOX) in Patients with Advanced Oesophago-Gastric Cancer
	ISRCTN:	ISRCTN51678883
	Sponsor:	The Royal Marsden NHS Foundation Trust (UK)
	Date assigned:	15 October 2002

7764	A randomised two-arm, prospective, multi-centre, open-label phase III trial comparing the activity and safety of a weekly versus a three-weekly paclitaxel treatment schedule in patients with advanced or metastatic breast cancer
	ISRCTN:	ISRCTN52817670
	Sponsor:	Anglo Celtic Cooperative Oncology Group (UK)
	Date assigned:	15 October 2002

7765	A Phase III study of Radical Radiotherapy with or without Gemcitabine in Patients with T1-2 N0-1 M0 Non-Small Cell Lung Cancer (NSCLC)
	ISRCTN:	ISRCTN61727489
	Sponsor:	University of Edinburgh
	Date assigned:	15 October 2002

7766	A multi-centred randomised study of parotid sparing intensity modulated radiotherapy (IMRT) to reduce xerostomia and increase quality of life in head and neck cancer
	ISRCTN:	ISRCTN48243537
	Sponsor:	The Institute of Cancer Research (UK)
	Date assigned:	15 October 2002

7767	An investigation into the use of relaxation therapy as an intervention for hot flushes in women who have had breast cancer
	ISRCTN:	ISRCTN15126436
	Sponsor:	Cancer Research UK (CRUK) (UK)
	Date assigned:	15 October 2002

7768	Double-blind, placebo-controlled, randomised phase 2 trial of IH636 grape seed proanthocyanidin (GSPE) in patients with adverse effects of high dose breast radiotherapy
	ISRCTN:	ISRCTN72553848
	Sponsor:	The Royal Marsden NHS Foundation Trust (UK)
	Date assigned:	15 October 2002

7769	HERA: A randomised three-arm multi-centre comparison of 1 year and 2-years of Herceptin® versus no Herceptin® in women with HER2-positive primary breast cancer who have completed adjuvant chemotherapy
	ISRCTN:	ISRCTN82811952
	Sponsor:	Roche Products Limited (UK)
	Date assigned:	15 October 2002

7770	Low-dose doxycycline in the treatment of periodontitis in smokers
	ISRCTN:	ISRCTN11033714
	Sponsor:	CollaGenex Pharmaceuticals Inc. (USA)
	Date assigned:	15 October 2002

RESULT PAGE

777